Sustained resveratrol infusion increases natriuresis independent of renal vasodilation

Resveratrol is reported to exert cardio‐renal protective effects in animal models of pathology, yet the mechanisms underlying these effects are poorly understood. Previously, we reported an i.v . bolus of resveratrol induces renal vasodilation by increasing nitric oxide bioavailability and inhibiting reactive oxygen species. Thus, we hypothesized a sustained infusion of resveratrol would also increase renal blood flow ( RBF ), and additionally glomerular filtration rate ( GFR ). We infused vehicle for 30 min followed by 30 min resveratrol at either: 0, 0.5, 1.0, 1.5 mg/min, and measured RBF , renal vascular resistance ( RVR ), GFR , and urinary sodium excretion. At all three doses, blood pressure and GFR remained unchanged. Control RBF was 7.69 ± 0.84 mL/min/gkw and remained unchanged by 0.5 mg/min resveratrol (7.88 ± 0.94 mL/min/gkw, n  = 9), but urinary sodium excretion increased from 2.19 ± 1.1 to 5.07 ± 0.92 μ mol/min/gkw ( n  = 7, P  < 0.01). In separate experiments, 1.0 mg/min resveratrol increased RBF by 17%, from 7.16 ± 0.29 to 8.35 ± 0.42 mL/min/gkw ( P  < 0.01, n  = 10), decreased RVR 16% from 13.63 ± 0.65 to 11.36 ± 0.75 ARU ( P  < 0.003) and increased sodium excretion from 1.57 ± 0.46 to 3.10 ± 0.80  μ mol/min/gkw ( n  = 7, P  < 0.04). At the 1.5 mg/min dose, resveratrol increased RBF 12% from 6.76 ± 0.57 to 7.58 ± 0.60 mL/min/gkw ( n  = 8, P  < 0.003), decreased RVR 15% (15.58 ± 1.35 to 13.27 ± 1.14 ARU , P  < 0.003) and increased sodium excretion (3.99 ± 1.71 to 7.80 ± 1.51  μ mol/min/gkw, n  = 8, P  < 0.04). We conclude that a constant infusion of resveratrol can induce significant renal vasodilation while not altering GFR or blood pressure. Also, resveratrol infusion produced significant natriuresis at all doses, suggesting it may have a direct effect on renal tubular sodium handling independent of renal perfusion pressure or flow.